Asian Journal of Biomedical and Pharmaceutical Sciences

Reach Us +1 (202) 780-3397

Commentary - Asian Journal of Biomedical and Pharmaceutical Sciences (2025) Volume 15, Issue 10

The future of medicine: Transforming healthcare through precision medicine

Aisha Rahman*

Department of Biomedical Sciences, University of Malaya, Malaysia

*Corresponding Author:
Aisha Rahman
Department of Biomedical Sciences
University of Malaya, Malaysia
E-mail: Aisha@um.edu.my

Received: 01-Mar-2025, Manuscript No. AABPS-25 -166459; Editor assigned: 03-Mar-2025, Pre QC No. AABPS-25-166459(PQ); Reviewed: 17-Mar-2025, QC No. AABPS-24-166459; Revised: 21-Mar-2025, Manuscript No. AABPS-25-166459(R); Published: 28-Mar-2025, DOI: 10.35841/aabps-15.110.281

Citation: Rahman A. The future of medicine: Transforming healthcare through precision medicine. Asian J Biomed Pharm Sci. 2025;15(110):281

Introduction

The landscape of modern medicine is undergoing a profound transformation through the adoption of precision medicine, a revolutionary approach that tailors medical treatment to the individual characteristics of each patient. By integrating genetic, environmental, and lifestyle factors, precision medicine enhances the ability to predict disease susceptibility, improve diagnosis, and customize therapeutic strategies. This paradigm shift promises to redefine patient care, making treatments more effective and significantly reducing adverse drug reactions [1].

Precision medicine, also referred to as personalized medicine, involves the customization of healthcare based on an individual’s genetic profile. Unlike traditional practices that rely on generalized treatments for large populations, precision medicine emphasizes the uniqueness of each patient. It considers genetic variants that affect how individuals respond to medications, thereby enabling clinicians to prescribe the right drug at the right dose for the right person [2].

At the heart of precision medicine lies pharmacogenomics— the study of how genes influence drug response. Key gene variants such as CYP2C19, CYP2D6, and TPMT are known to significantly alter the metabolism of common medications. Incorporating pharmacogenomic testing into clinical settings allows for more informed treatment decisions, optimizing therapeutic outcomes while minimizing adverse drug reactions and toxicities [3].

Adverse drug reactions (ADRs) remain a major cause of hospitalization and treatment failure worldwide. Precision medicine addresses this issue by enabling genetic screening before prescribing medications. Through targeted testing, healthcare professionals can predict which patients are at risk of experiencing side effects, thereby enhancing patient safety and reducing healthcare costs [4].

Precision medicine has shown transformative potential in treating chronic conditions such as cancer, cardiovascular disease, and diabetes. In oncology, therapies such as trastuzumab for HER2-positive breast cancer and imatinib for chronic myeloid leukemia demonstrate the power of genetic targeting. For cardiovascular patients, genetic-guided use of anticoagulants like warfarin helps in achieving precise dosage and avoiding complications [5].

Psychiatric treatments often involve trial-and-error methods due to unpredictable drug responses. Precision medicine is beginning to transform psychiatry by identifying genetic markers associated with mental health disorders and psychotropic drug metabolism. This not only improves treatment efficacy but also reduces the burden of adverse psychological side effects [6].

Emerging technologies such as artificial intelligence (AI) and machine learning are accelerating the integration of precision medicine into clinical practice. AI-driven platforms can analyze massive datasets from genomic sequences to electronic health records—to assist in diagnosis, predict treatment responses, and personalize therapy in real time. These innovations are reshaping the healthcare delivery model toward a more datadriven, patient-centric system [7].

Despite its promise, precision medicine faces several challenges. The cost of genomic testing remains high in many regions, limiting accessibility. Concerns around data privacy, ethical consent, and genetic discrimination also need urgent attention. Equitable implementation of precision medicine requires policies that ensure all populations benefit, regardless of socioeconomic status or geographic location [8].

The future of healthcare lies in widespread adoption of precision medicine. Advancements in biotechnology, genome sequencing, and bioinformatics are expected to expand its reach. International collaborations and investment in largescale genomic databases will further improve the accuracy and affordability of personalized treatments. As this field evolves, education and training for healthcare providers will be crucial to integrate these technologies into everyday clinical practice [9, 10].

Conclusion

Precision medicine marks a revolutionary step in personalized healthcare, offering customized treatment strategies that align with a patient’s genetic and biological makeup. Through the integration of genomics, AI, and pharmacogenomics, precision medicine is not only improving therapeutic outcomes but also redefining standards in clinical care. Although challenges remain, continued research, technological innovation, and policy support will shape a future where medicine is more predictive, preventive, and precise—bringing true personalization to global health.

References

  1. Molassiotis A, Potrata B, Cheng KK. A systematic review of the effectiveness of Chinese herbal medication in symptom management and improvement of quality of life in adult cancer patients. Complement Ther Med. 2009;17(2):92-120.

    2. Indexed at, Google Scholar, Crossref

  2. Borgmann E. Art therapy with three women diagnosed with cancer. Arts Psychother. 2002;29(5):245-51.

    3. Indexed at, Google Scholar, Crossref

  3. Greece M. Art therapy on a bone marrow transplant unit: the case study of a Vietnam veteran fighting myelofibrosis. Arts Psychother. 2003;30(4):229-38.

    4. Indexed at, Google Scholar, Crossref

  4. Heywood K. Introducing art therapy into the Christie Hospital Manchester UK 2001–2002. Complement Ther Nurs Midwifery. 2003;9(3):125-32.

    5. Indexed at, Google Scholar, Crossref

  5. Nainis N, Paice JA, Ratner J, et al. Relieving symptoms in cancer: innovative use of art therapy. J Pain Symptom Manag. 2006;31(2):162-9.

    6. Indexed at, Google Scholar, Crossref

  6. Puig A, Lee SM, Goodwin L, Sherrard PA. The efficacy of creative arts therapies to enhance emotional expression, spirituality, and psychological well-being of newly diagnosed Stage I and Stage II breast cancer patients: A preliminary study. Arts Psychother. 2006;33(3):218-28.

    7. Indexed at, Google Scholar, Crossref

  7. Leung YW, Grewal K, Stewart DE, et al. Gender differences in motivations and perceived effects of Mind–Body Therapy (MBT) practice and views on integrative cardiac rehabilitation among acute coronary syndrome patients: Why do women use MBT?. Complement Ther Med. 2008;16(6):311-7.

    8. Indexed at, Google Scholar, Crossref

  8. Visser A, OpT Hoog M. Education of creative art therapy to cancer patients: Evaluation and effects. J Cancer Educ. 2008;23(2):80-4.

    9. Indexed at, Google Scholar, Crossref

  9. Ponto JA. Stories of breast cancer through art. Oncol Nur Soc. 2003;30(6):1007-13.

    10. Indexed at, Google Scholar, Crossref

  10. Collie K, Bottorff JL, Long BC. A narrative view of art therapy and art making by women with breast cancer. J Health Psychol. 2006;11(5):761-75.

    11. Indexed at, Google Scholar, Crossref

Get the App